Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery

Correction

Published on 06 Jan 2025

Corrigendum: Ginkgolide C alleviates myocardial ischemia/reperfusion-induced inflammatory injury via inhibition of CD40-NF-κB pathway

in Experimental Pharmacology and Drug Discovery

Rui Zhang
Dan Han
Zhenyu Li
Chengwu Shen
Yahui Zhang
Jun Li
Genquan Yan
Shasha Li
Bo Hu
Jiangbing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1492520

689 views

Original Research

Published on 06 Jan 2025

Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy

in Experimental Pharmacology and Drug Discovery

Sumin Sun
Haili Hu
Feiyu Li
Sheng Huan
Long Chen
Jiahui Chen
Peihua Sun
Xiaoqing Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503490

1,334 views

Original Research

Published on 06 Jan 2025

Biological activities of Usnea lethariiformis lichen extracts and UHPLC-ESI-QTOF-MS analysis of their secondary metabolites

in Experimental Pharmacology and Drug Discovery

Mauricio Piñeiro
Sofía Manrique
Jessica Gómez
Juan Manuel Rodriguez
Patricia Barrera
Duilio Caballero
Miguel A. Sosa
Gabriel Vargas-Arana
Alejandro Tapia
Beatriz Lima

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508835

1,834 views
1 citation

Review

Published on 06 Jan 2025

An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway

in Experimental Pharmacology and Drug Discovery

Pratibha Pandey
Sorabh Lakhanpal
Danish Mahmood
Han Na Kang
Byunggyu Kim
Sojin Kang
Jinwon Choi
Min Choi
Shivam Pandey
Mahakshit Bhat

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513422

2,854 views
7 citations

Original Research

Published on 06 Jan 2025

A study to assess the pharmacological agent potential of gold nanoparticles and their effects on human cancer cells and hospital pathogens using in vitro methods

in Experimental Pharmacology and Drug Discovery

Ayşe Baran

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498734

537 views

Review

Published on 06 Jan 2025

Plant and marine-derived natural products: sustainable pathways for future drug discovery and therapeutic development

in Experimental Pharmacology and Drug Discovery

Muhammad Ahmad
Maleha Tahir
Zibin Hong
Muhammad Anjum Zia
Hamza Rafeeq
Muhammad Shaheez Ahmad
Saif ur Rehman
Junming Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497668

4,301 views
3 citations

Original Research

Published on 03 Jan 2025

Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats

in Experimental Pharmacology and Drug Discovery

Izzet Emir
Seval Bulut
Bahadır Suleyman
Renad Mammadov
Nurinisa Yucel
Betul Cicek
Gulce Naz Yazici
Durdu Altuner
Murat Gunay
Halis Suleyman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503032

1,112 views

Original Research

Published on 03 Jan 2025

Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice

in Experimental Pharmacology and Drug Discovery

XuWen Mao
Guliruoyi Paerhati
Yuche Wu
Lu Feng Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499142

1,591 views
2 citations

Original Research

Published on 03 Jan 2025

Protein-ligand binding affinity prediction using multi-instance learning with docking structures

in Experimental Pharmacology and Drug Discovery

Hyojin Kim
Heesung Shim
Aditya Ranganath
Stewart He
Garrett Stevenson
Jonathan E. Allen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1518875

2,186 views

Review

Published on 24 Dec 2024

Large language models facilitating modern molecular biology and novel drug development

in Experimental Pharmacology and Drug Discovery

Xiao-huan Liu
Zhen-hua Lu
Tao Wang
Fei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458739

2,945 views
3 citations

Review

Published on 23 Dec 2024

Exosomal communication: a pivotal regulator of bone homeostasis and a potential therapeutic target

in Experimental Pharmacology and Drug Discovery

Qian-Yun Ye
Yan Cui
Hao-Yu Wang
Ling-Yu Li
Jian-Bing Chen
Xiao-Feng Zhu
Zhi-Jian Xue
Rong-Hua Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516125

1,558 views
1 citation

Original Research

Published on 23 Dec 2024

Biocompatible nanoparticles self-assembled by PEGylated polyphosphoesters for combination of photodynamic therapy and hypoxia-activated chemotherapy against breast cancer

in Experimental Pharmacology and Drug Discovery

Fengyu Wang
Xiaojing Zou
Chunyang Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1529631

955 views

Original Research

Published on 20 Dec 2024

The novel pleuromutilin derivative 22–((4-((4-nitrophenyl)acetamido)phenyl)thio)deoxy pleuromutilin possesses robust anti-mycoplasma activity both in vitro and in vivo

in Experimental Pharmacology and Drug Discovery

Xirui Xia
Xuan Ji
Yaxi Li
Yubo Wang
Yue Zhao
Wenxiang Wang
Huanzhong Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491223

1,256 views

Review

Published on 20 Dec 2024

β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress

in Experimental Pharmacology and Drug Discovery

Szymon Drygała
Michał Radzikowski
Mateusz Maciejczyk

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489657

3,682 views
2 citations

Systematic Review

Published on 20 Dec 2024

Effect of icariin on ovarian cancer: a combined network pharmacology and meta-analysis of in vitro studies approach

in Experimental Pharmacology and Drug Discovery

Shang-Mei Cao
Bo-Lin Chen
Zhen-Zhen Zou
Shao-Zhe Yang
Xiu-Hong Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418111

1,394 views
1 citation

Correction

Published on 19 Dec 2024

Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex

in Experimental Pharmacology and Drug Discovery

Yongmei Feng
Stefan Grotegut
Predrag Jovanovic
Valentina Gandin
Steven H. Olson
Rabi Murad
Anne Beall
Sharon Colayco
Paul De-Jesus
Sumit Chanda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528449

1,029 views